| Groups (observations) |
Estimated mean urine glucose |
Standard error |
|
| 1-control (n=38) |
2.98 |
0.052 |
|
| 2-H (PLB) (n=97) |
2.43 |
0.032 |
|
| 3-M (PLB) (n=97) |
2.28 |
0.032 |
|
| 4-L (PLB) (n=97) |
2.11 |
0.032 |
|
| 5-health (n=62) |
0.17 |
0.040
|
|
| Treatment |
Mean difference |
Standard error |
P-value |
| 1 vs. 2 |
0.55 |
0.061 |
< 0.0001 |
| 1 vs. 3 |
0.70 |
0.061 |
< 0.0001 |
| 1 vs. 4 |
0.87 |
0.061 |
< 0.0001 |
| 1 vs. 5 |
2.81 |
0.066 |
< 0.0001 |
| 2 vs. 3 |
0.15 |
0.046 |
0.0010 |
| 2 vs. 4 |
0.32 |
0.046 |
< 0.0001 |
| 2 vs. 5 |
2.26 |
0.052 |
< 0.0001 |
| 3 vs. 4 |
0.17 |
0.046 |
0.0002 |
| 3 vs. 5 |
2.11 |
0.052 |
< 0.0001 |
| 4 vs. 5 |
1.94 |
0.052 |
< 0.0001 |
Note: control is diabetic rats without PLB treatment; H, M, and L groups are high, moderate, and low glucosuria of diabetic rates, respectively with PLB treatment; health
group is healthy rats. Observation is number of measured urine glucose from two rats in each group within 10 weeks of experimental period. P-value < 0.05 means
significant difference of comparison of two groups. |
